Sars-COV-2 (COVID-19) Immunity in immunoCOmpromised Populations (COVICO)
SARS CoV 2 Infection, COVID-19
About this trial
This is an interventional diagnostic trial for SARS CoV 2 Infection
Eligibility Criteria
Inclusion Criteria: Being a resident or member of staff in a nursing home and having participated in the previously organized PICOV-VAC study. Being cognitively capable to give consent to participate in the study. Being a healthy adults and having participated in the previous REDU-VAC study Being a kidney transplant or dialysis patient and having participated in the previous NEPHRO-VAC study Being a lung transplant patient and having participated in the previous LUNG-VAC study Exclusion Criteria: Having insufficient knowledge of the Dutch or French language.. Having a previous diagnosis of dementia and/or having a mini-mental state examination (MMSE) score < 18/30. Having veins which are not accessible for simple peripheral blood puncture.
Sites / Locations
- Sciensano
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Experimental
Residents and staff from nursing homes from the previous PICOV-VAC study
Healthy adults from the previous REDU-VAC study
Kidney transplant and dialysis patients from the previous NEPHRO-VAC study
Lung transplant patients from the previous LUNG-VAC study